Research location
Waterloo
Iowa, United States
Advertisement
Research activity in Waterloo
Iowa, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 123 trials and 135 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Waterloo
123 linked trials · page 2 of 3Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreNCT01617954 · 2012-05-01 · 1 site observation
COMPLETED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung CancerNCT01360554 · 2011-06-16 · 1 site observation
COMPLETED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08 · 1 site observation
COMPLETED
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerNCT01107626 · 2010-10-25 · 1 site observation
COMPLETED
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin TreatmentNCT01125566 · 2010-06-22 · 1 site observation
COMPLETED
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung CancerNCT01138163 · 2010-06-01 · 1 site observation
COMPLETED
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung CancerNCT01160601 · 2010-06-01 · 1 site observation
COMPLETED
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseNCT01042977 · 2010-03-01 · 1 site observation
COMPLETED
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabNCT01009918 · 2010-03-01 · 1 site observation
COMPLETED
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial DisparitiesNCT00935077 · 2010-01-01 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementNCT00869206 · 2009-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesNCT00838916 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Albiglutide in Type 2 DiabetesNCT00849017 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide in Type 2 DiabetesNCT00849056 · 2009-01-01 · 1 site observation
COMPLETED
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyNCT00769379 · 2008-12-10 · 1 site observation
COMPLETED
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCNCT00828841 · 2008-12-01 · 1 site observation
COMPLETED
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerNCT00785291 · 2008-10-13 · 2 site observations
COMPLETED
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung CancerNCT00738881 · 2008-10-01 · 1 site observation
TERMINATED
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination ChemotherapyNCT00693992 · 2008-06-15 · 1 site observation
COMPLETED
Trial Of CP-751, 871 And Erlotinib In Refractory Lung CancerNCT00673049 · 2008-05-01 · 1 site observation
TERMINATED
APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerNCT00652340 · 2008-04-01 · 1 site observation
COMPLETED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02 · 2 site observations
ACTIVE_NOT_RECRUITING
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUNCT00520975 · 2007-11-01 · 1 site observation
TERMINATED
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryNCT00324805 · 2007-07-19 · 2 site observations
COMPLETED
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerNCT00509769 · 2007-07-01 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusNCT00760344 · 2007-03-01 · 1 site observation
COMPLETED
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)NCT00450970 · 2007-02-01 · 1 site observation
TERMINATED
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast CancerNCT00666731 · 2006-10-12 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 2 site observations
COMPLETED
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminNCT00386100 · 2006-10-01 · 1 site observation
COMPLETED
S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoNCT00382018 · 2006-10-01 · 1 site observation
COMPLETED
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNCT00382070 · 2006-08-01 · 2 site observations
UNKNOWN
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyNCT00134056 · 2006-08-01 · 2 site observations
COMPLETED
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerNCT00338247 · 2006-07-01 · 1 site observation
APPROVED_FOR_MARKETING
Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk ProgramNCT00401726 · 2006-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.NCT00328627 · 2006-05-01 · 1 site observation
COMPLETED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 2 site observations
ACTIVE_NOT_RECRUITING
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or AnastrozoleNCT00316836 · 2006-04-01 · 2 site observations
COMPLETED
Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation
COMPLETED
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)NCT00257608 · 2006-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.